Navigation Links
2 Springer authors receive NWO/Spinoza Prize in the Netherlands
Date:6/24/2009

The Netherlands Organisation for Scientific Research (NWO) has announced the winners of the NWO/Spinoza Prize for 2009. Two of the three laureates of this year's Prize are Springer authors, Marten Scheffer and Albert van den Berg. The prize, also viewed as the 'Dutch Nobel Prize,' is the highest Dutch award in science and is given for outstanding, pioneering and inspiring research.

Previously, the prize amount was EUR 1.5 million, but this year, each of the three researchers will receive EUR 2.5 million to spend on research of their choice. Dutch Education Minister Ronald Plasterk will officially present the prizes on 25 November 2009 in the Nieuwe Kerk in The Hague, Netherlands.

Professor Marten Scheffer is an aquatic ecologist at Wageningen University and Research Centre and has made pioneering contributions to our understanding of critical transitions in complex systems, varying from transitions in shallow lakes to climate change and the collapse of ancient cultures. Dr. Scheffer published his book Ecology of Shallow Lakes with Springer.

Professor Albert van den Berg is a physicist at the University of Twente, and has made key breakthroughs in the understanding and manipulation of fluids in micro- and nanochannels, and has applied this knowledge to areas such as the development of new medical equipment. Dr. van den Berg is co-author of the Springer book Lab-on-Chips for Cellomics and co-editor of the proceedings volumes Micro Total Analysis Systems.

The WO/Spinoza Prize is awarded to Dutch researchers who rank among the world's top scientists. The laureates are internationally renowned and know how to inspire young researchers. This is the fifteenth occasion on which the Spinoza Prizes have been awarded.


'/>"/>

Contact: Joan Robinson
joan.robinson@springer.com
49-622-148-78130
Springer
Source:Eurekalert

Page: 1

Related biology technology :

1. Springer publishes anthology with the Nanoethics Group
2. Nanoscale carbon materials research wins the 2008 Julius Springer Prize for Applied Physics
3. PNAS paper and its authors honored for scientific excellence
4. You: Being Beautiful Authors Mehmet Oz, MD, & Michael Roizen, MD, Call Ribose One of the Decades Real Nutritional Heroes
5. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
6. Ciphergen Biosystems Receives Noncompliance Letter From The Nasdaq Stock Market
7. Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
8. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
9. IsoTis Receives FDA Clearance for Accell Family of Products
10. Actavis Receives Approval of Fentanyl Transdermal System in the U.S.
11. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... ... April 26, 2017 , ... NextSteps 2017, ... North America this May on the following dates: , ?    London, UK ... Chairman of the Learning and Performance Institute will be the opening keynote ...
(Date:4/25/2017)... ... ... As part of the Stago EdVantage Virtual University Virtual Event, ... order to illuminate this clinical problem for people unfamiliar with the topic. , DIC ... high degree of morbidity and mortality. DIC is a confusing disorder from both diagnostic ...
(Date:4/25/2017)... , April 25, 2017 ... has licensed its novel immune-modulating technology to an undisclosed ... and allergy. Tregitopes, pronounced T·rej·itopes, are ... immunoglobulin by EpiVax CEO Annie De Groot ... intravenous immunoglobulin G, an autoimmune disease therapy, Tregitopes ...
(Date:4/25/2017)... ... 2017 , ... Leaders of Quorum Review IRB and Kinetiq ... at this week’s Association of Clinical Research Professionals (ACRP) 2017 Meeting & Expo ... , "We are excited to present subject matter expertise on topics that impact the ...
Breaking Biology Technology:
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
(Date:3/30/2017)... NEW YORK , March 30, 2017 ... by type (physiological and behavioral), by technology (fingerprint, AFIS, ... recognition, voice recognition, and others), by end use industry ... travel and immigration, financial and banking, and others), and ... Europe , Asia Pacific ...
(Date:3/27/2017)... , March 27, 2017  Catholic Health Services ... Management Systems Society (HIMSS) Analytics for achieving Stage ... Model sm . In addition, CHS previously earned ... hospitals using an electronic medical record (EMR). ... high level of EMR usage in an outpatient ...
Breaking Biology News(10 mins):